CBX5 and transient ischemic attack: AlphaLISA using recombinant antigen proteins demonstrated that the levels of antibodies against MMP1, CBX1, and CBX5 were higher in patients with TIA or aCI than in HDs, suggesting that these antibody markers are valuable for the diagnosis of TIA and aCI.